Nanotechnology Breakthroughs in the Early Diagnosis of Alzheimer's Disease

DOI:

https://doi.org/10.37285/ijpsn.2024.17.4.13

Authors

  • Kuldeep Vinchurkar a:1:{s:5:"en_US";s:37:"Ph. D, Research Scholar, DAVV, Indore";}
  • Rohit Doke
  • Ajay Bhagwat

Abstract

Dear Sir,

Alzheimer's Disease (AD) is an advancing neurological condition marked by diminishing cognitive functions, memory deterioration, and diminished functional skills. It stands as the primary contributor to dementia, encompassing roughly 60-80% of dementia occurrences. Generally affecting the elderly population, particularly those aged 65 and above (10%), and even more prominently in individuals aged 85 and older (30%), the likelihood of developing AD escalates with advancing age. The Key pathological features of AD include the accumulation of amyloid-beta (Aβ) plaques, tau protein build-up, oxidative stress, and immune inflammation. The complexity and unclear nature of AD's pathogenesis make early detection and timely treatment difficult. Nanotechnology, with its distinct physical, electrical, magnetic, and optical properties, shows significant promise in AD detection and treatment. We have explored the recent advancements in applications of nanoparticles (NPs) for AD detection. Additionally, we emphasize significant progress in nanotechnology-based treatment strategies, and challenges and propose future directions for nanotechnology in AD diagnosis and intervention1.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Alzheimer's Disease , Nanotechnology, Early Diagnosis, paired helical fibril

Published

2024-08-15

How to Cite

1.
Vinchurkar K, Rohit Doke, Ajay Bhagwat. Nanotechnology Breakthroughs in the Early Diagnosis of Alzheimer’s Disease. Scopus Indexed [Internet]. 2024 Aug. 15 [cited 2024 Oct. 13];17(4):7558-9. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/5809

Issue

Section

Letter to Editor

References

Nasb M, Tao W, Chen N. Alzheimer’s Disease Puzzle: Delving into Pathogenesis Hypotheses. Aging Dis. 2024;15(1):43–73.

Agraharam G, Saravanan N, Girigoswami A, Girigoswami K. Future of Alzheimer’s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach. Bionanoscience. 2022;12(3):1002–17.

Song N, Sun S, Chen K, Wang Y, Wang H, Meng J, et al. Emerging nanotechnology for Alzheimer’s disease: From detection to treatment. J Control Release. 2023; 360:392–417.